• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

双底物抑制剂的烟酰胺 -N- 甲基转移酶 (NNMT),具有增强的活性。

Bisubstrate Inhibitors of Nicotinamide -Methyltransferase (NNMT) with Enhanced Activity.

机构信息

Biological Chemistry Group, Institute of Biology Leiden , Leiden University , Sylviusweg 72 , 2333 BE Leiden , The Netherlands.

Department of Clinical Sciences , Universitá Politecnica delle Marche , Via Ranieri 65 , 60131 Ancona , Italy.

出版信息

J Med Chem. 2019 Jul 25;62(14):6597-6614. doi: 10.1021/acs.jmedchem.9b00413. Epub 2019 Jul 12.

DOI:10.1021/acs.jmedchem.9b00413
PMID:31265285
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6713424/
Abstract

Nicotinamide -methyltransferase (NNMT) catalyzes the methylation of nicotinamide to form -methylnicotinamide. Overexpression of NNMT is associated with a variety of diseases, including a number of cancers and metabolic disorders, suggesting a role for NNMT as a potential therapeutic target. By structural modification of a lead NNMT inhibitor previously developed in our group, we prepared a diverse library of inhibitors to probe the different regions of the enzyme's active site. This investigation revealed that incorporation of a naphthalene moiety, intended to bind the hydrophobic nicotinamide binding pocket via π-π stacking interactions, significantly increases the activity of bisubstrate-like NNMT inhibitors (half-maximal inhibitory concentration 1.41 μM). These findings are further supported by isothermal titration calorimetry binding assays as well as modeling studies. The most active NNMT inhibitor identified in the present study demonstrated a dose-dependent inhibitory effect on the cell proliferation of the HSC-2 human oral cancer cell line.

摘要

烟酰胺 -N- 甲基转移酶(NNMT)催化烟酰胺的甲基化形成甲基烟酰胺。NNMT 的过表达与多种疾病相关,包括多种癌症和代谢紊乱,这表明 NNMT 可能是一个有治疗潜力的靶点。通过对我们之前在本课题组开发的一种 NNMT 抑制剂进行结构修饰,我们制备了一个多样化的抑制剂文库,以探究酶活性位点的不同区域。这项研究表明,引入萘基部分旨在通过π-π 堆积相互作用与疏水性烟酰胺结合口袋结合,可显著提高双底物样 NNMT 抑制剂的活性(半最大抑制浓度为 1.41 μM)。这些发现得到了等温滴定量热法结合实验和建模研究的进一步支持。在本研究中鉴定出的最有效的 NNMT 抑制剂对人口腔癌细胞系 HSC-2 的细胞增殖表现出剂量依赖性抑制作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0e5/6713424/35ebb6560d60/jm-2019-00413d_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0e5/6713424/54b0d19b1d55/jm-2019-00413d_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0e5/6713424/f47d3d1ee465/jm-2019-00413d_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0e5/6713424/99ee358e5237/jm-2019-00413d_0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0e5/6713424/e97713810a38/jm-2019-00413d_0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0e5/6713424/93810236c3a0/jm-2019-00413d_0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0e5/6713424/da94e0c71648/jm-2019-00413d_0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0e5/6713424/f2341e902b02/jm-2019-00413d_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0e5/6713424/4d6072cfe1cd/jm-2019-00413d_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0e5/6713424/502c19c1c0f6/jm-2019-00413d_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0e5/6713424/35ebb6560d60/jm-2019-00413d_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0e5/6713424/54b0d19b1d55/jm-2019-00413d_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0e5/6713424/f47d3d1ee465/jm-2019-00413d_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0e5/6713424/99ee358e5237/jm-2019-00413d_0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0e5/6713424/e97713810a38/jm-2019-00413d_0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0e5/6713424/93810236c3a0/jm-2019-00413d_0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0e5/6713424/da94e0c71648/jm-2019-00413d_0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0e5/6713424/f2341e902b02/jm-2019-00413d_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0e5/6713424/4d6072cfe1cd/jm-2019-00413d_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0e5/6713424/502c19c1c0f6/jm-2019-00413d_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0e5/6713424/35ebb6560d60/jm-2019-00413d_0005.jpg

相似文献

1
Bisubstrate Inhibitors of Nicotinamide -Methyltransferase (NNMT) with Enhanced Activity.双底物抑制剂的烟酰胺 -N- 甲基转移酶 (NNMT),具有增强的活性。
J Med Chem. 2019 Jul 25;62(14):6597-6614. doi: 10.1021/acs.jmedchem.9b00413. Epub 2019 Jul 12.
2
Inhibitors of nicotinamide N-methyltransferase designed to mimic the methylation reaction transition state.设计用于模拟甲基化反应过渡态的烟酰胺N-甲基转移酶抑制剂。
Org Biomol Chem. 2017 Aug 9;15(31):6656-6667. doi: 10.1039/c7ob01357d.
3
Potent Inhibition of Nicotinamide -Methyltransferase by Alkene-Linked Bisubstrate Mimics Bearing Electron Deficient Aromatics.带有缺电子芳烃的烯烃连接双底物模拟物对烟酰胺 - 甲基转移酶的强效抑制作用
J Med Chem. 2021 Sep 9;64(17):12938-12963. doi: 10.1021/acs.jmedchem.1c01094. Epub 2021 Aug 23.
4
High-Affinity Alkynyl Bisubstrate Inhibitors of Nicotinamide -Methyltransferase (NNMT).高亲和性炔基双底物抑制剂烟酰胺 -N- 甲基转移酶(NNMT)。
J Med Chem. 2019 Nov 14;62(21):9837-9873. doi: 10.1021/acs.jmedchem.9b01238. Epub 2019 Oct 25.
5
Covalent inhibitors of nicotinamide N-methyltransferase (NNMT) provide evidence for target engagement challenges in situ.烟酰胺N-甲基转移酶(NNMT)的共价抑制剂为原位靶点结合挑战提供了证据。
Bioorg Med Chem Lett. 2018 Sep 1;28(16):2682-2687. doi: 10.1016/j.bmcl.2018.04.017. Epub 2018 Apr 10.
6
Interferon-gamma elevates nicotinamide N-methyltransferase activity and nicotinamide level in human glioma cells.干扰素-γ可提高人胶质瘤细胞中烟酰胺N-甲基转移酶的活性及烟酰胺水平。
J Nutr Sci Vitaminol (Tokyo). 2010;56(2):83-6. doi: 10.3177/jnsv.56.83.
7
Structure-Activity Relationship for Small Molecule Inhibitors of Nicotinamide N-Methyltransferase.小分子烟酰胺 N-甲基转移酶抑制剂的构效关系。
J Med Chem. 2017 Jun 22;60(12):5015-5028. doi: 10.1021/acs.jmedchem.7b00389. Epub 2017 Jun 12.
8
Nicotinamide N-methyl transferase (NNMT): An emerging therapeutic target.烟酰胺N-甲基转移酶(NNMT):一个新兴的治疗靶点。
Drug Discov Today. 2021 Nov;26(11):2699-2706. doi: 10.1016/j.drudis.2021.05.011. Epub 2021 May 21.
9
Discovery of Bisubstrate Inhibitors of Nicotinamide N-Methyltransferase (NNMT).发现烟酰胺 N-甲基转移酶(NNMT)的双底物抑制剂。
J Med Chem. 2018 Feb 22;61(4):1541-1551. doi: 10.1021/acs.jmedchem.7b01422. Epub 2018 Jan 31.
10
Novel nicotinamide analog as inhibitor of nicotinamide N-methyltransferase.新型烟酰胺类似物作为烟酰胺N-甲基转移酶的抑制剂
Bioorg Med Chem Lett. 2018 Mar 1;28(5):922-925. doi: 10.1016/j.bmcl.2018.01.058. Epub 2018 Jan 31.

引用本文的文献

1
Current Trends in Clinical Trials for Merkel Cell Carcinoma (MCC).默克尔细胞癌(MCC)临床试验的当前趋势
Cancers (Basel). 2025 Jul 15;17(14):2340. doi: 10.3390/cancers17142340.
2
Nicotinamide N-Methyltransferase (NNMT) and Liver Cancer: From Metabolic Networks to Therapeutic Targets.烟酰胺N-甲基转移酶(NNMT)与肝癌:从代谢网络到治疗靶点
Biomolecules. 2025 May 14;15(5):719. doi: 10.3390/biom15050719.
3
Mechanism and kinetics of turnover inhibitors of nicotinamide N-methyl transferase in vitro and in vivo.烟酰胺N-甲基转移酶周转抑制剂在体外和体内的作用机制及动力学

本文引用的文献

1
High-Affinity Alkynyl Bisubstrate Inhibitors of Nicotinamide -Methyltransferase (NNMT).高亲和性炔基双底物抑制剂烟酰胺 -N- 甲基转移酶(NNMT)。
J Med Chem. 2019 Nov 14;62(21):9837-9873. doi: 10.1021/acs.jmedchem.9b01238. Epub 2019 Oct 25.
2
Overexpression of nicotinamide N-methyltransferase in HSC-2 OSCC cell line: effect on apoptosis and cell proliferation.在 HSC-2 OSCC 细胞系中过表达烟酰胺 N-甲基转移酶:对细胞凋亡和增殖的影响。
Clin Oral Investig. 2019 Feb;23(2):829-838. doi: 10.1007/s00784-018-2497-8. Epub 2018 Jun 7.
3
The kinetic analysis of the N-methylation of 4-phenylpyridine by nicotinamide N-methyltransferase: Evidence for a novel mechanism of substrate inhibition.
J Biol Chem. 2025 Apr 8;301(6):108492. doi: 10.1016/j.jbc.2025.108492.
4
Exploring NNMT: from metabolic pathways to therapeutic targets.探索NNMT:从代谢途径到治疗靶点。
Arch Pharm Res. 2024 Dec;47(12):893-913. doi: 10.1007/s12272-024-01519-9. Epub 2024 Nov 28.
5
Advances in the Synthesis and Physiological Metabolic Regulation of Nicotinamide Mononucleotide.烟酰胺单核苷酸的合成与生理代谢调控研究进展。
Nutrients. 2024 Jul 20;16(14):2354. doi: 10.3390/nu16142354.
6
Nicotinamide N-methyltransferase (NNMT): a novel therapeutic target for metabolic syndrome.烟酰胺N-甲基转移酶(NNMT):代谢综合征的新型治疗靶点。
Front Pharmacol. 2024 Jun 11;15:1410479. doi: 10.3389/fphar.2024.1410479. eCollection 2024.
7
Recent Advances in Drug Discovery for Triple-Negative Breast Cancer Treatment.三阴性乳腺癌治疗药物研发的最新进展。
Molecules. 2023 Nov 9;28(22):7513. doi: 10.3390/molecules28227513.
8
Nicotinamide N-methyltransferase (NNMT) regulates the glucocorticoid signaling pathway during the early phase of adipogenesis.烟酰胺 N-甲基转移酶 (NNMT) 在脂肪生成的早期阶段调节糖皮质激素信号通路。
Sci Rep. 2023 May 22;13(1):8293. doi: 10.1038/s41598-023-34916-z.
9
The Central Role of the NAD+ Molecule in the Development of Aging and the Prevention of Chronic Age-Related Diseases: Strategies for NAD+ Modulation.NAD+ 分子在衰老发展和预防慢性与年龄相关疾病中的核心作用:NAD+ 调节策略。
Int J Mol Sci. 2023 Feb 3;24(3):2959. doi: 10.3390/ijms24032959.
10
Integration of transcriptomics and metabolomics reveals a novel gene signature guided by FN1 associated with immune response in oral squamous cell carcinoma tumorigenesis.转录组学和代谢组学的整合揭示了一个由 FN1 介导的与口腔鳞状细胞癌肿瘤发生中的免疫反应相关的新型基因特征。
J Cancer Res Clin Oncol. 2023 Aug;149(9):6097-6113. doi: 10.1007/s00432-023-04572-x. Epub 2023 Jan 19.
烟酰胺 N-甲基转移酶催化 4-苯基吡啶 N-甲基化的动力学分析:底物抑制新机制的证据。
Int J Biochem Cell Biol. 2018 May;98:127-136. doi: 10.1016/j.biocel.2018.03.010. Epub 2018 Mar 13.
4
Type 2 diabetes-related proteins derived from an in vitro model of inflamed fat tissue.来源于炎症脂肪组织体外模型的 2 型糖尿病相关蛋白。
Arch Biochem Biophys. 2018 Apr 15;644:81-92. doi: 10.1016/j.abb.2018.03.003. Epub 2018 Mar 8.
5
A small molecule inhibitor of Nicotinamide N-methyltransferase for the treatment of metabolic disorders.烟酰胺 N-甲基转移酶小分子抑制剂治疗代谢紊乱。
Sci Rep. 2018 Feb 26;8(1):3660. doi: 10.1038/s41598-018-22081-7.
6
Novel nicotinamide analog as inhibitor of nicotinamide N-methyltransferase.新型烟酰胺类似物作为烟酰胺N-甲基转移酶的抑制剂
Bioorg Med Chem Lett. 2018 Mar 1;28(5):922-925. doi: 10.1016/j.bmcl.2018.01.058. Epub 2018 Jan 31.
7
Discovery of Bisubstrate Inhibitors of Nicotinamide N-Methyltransferase (NNMT).发现烟酰胺 N-甲基转移酶(NNMT)的双底物抑制剂。
J Med Chem. 2018 Feb 22;61(4):1541-1551. doi: 10.1021/acs.jmedchem.7b01422. Epub 2018 Jan 31.
8
Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high fat diet-induced obesity in mice.烟酰胺N-甲基转移酶的选择性和膜渗透性小分子抑制剂可逆转高脂饮食诱导的小鼠肥胖。
Biochem Pharmacol. 2018 Jan;147:141-152. doi: 10.1016/j.bcp.2017.11.007. Epub 2017 Nov 15.
9
Inhibitors of nicotinamide N-methyltransferase designed to mimic the methylation reaction transition state.设计用于模拟甲基化反应过渡态的烟酰胺N-甲基转移酶抑制剂。
Org Biomol Chem. 2017 Aug 9;15(31):6656-6667. doi: 10.1039/c7ob01357d.
10
Structure-Activity Relationship for Small Molecule Inhibitors of Nicotinamide N-Methyltransferase.小分子烟酰胺 N-甲基转移酶抑制剂的构效关系。
J Med Chem. 2017 Jun 22;60(12):5015-5028. doi: 10.1021/acs.jmedchem.7b00389. Epub 2017 Jun 12.